Dark

Check out our Level2View

EHVVF
EHAVE INC ORD
stock OTC

EOD

Aug 7, 2026

0.0012USD0.000%(0.0000)81,100

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 31, 2022

08:42AM EST Ehave, Inc., (OTC Pink: EHVVF) (the Company), a provider of digital therapeutics for the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Officer, Ben Kaplan. GlobeNewswire Inc

Dec 8, 2021

08:00AM EST Mycotopia and Ei.Ventures announced the signing of an LOI to explore a merger and the formation of PSLY.COM, a $360 Million transaction, and will apply to list shares on NASDAQ; Ehave plans to spin out 30% GlobeNewswire Inc

Oct 20, 2021

08:30AM EDT Ehave, Inc., (OTC Pink: EHVVF) (the Company), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its wholly owned KetaDASH will be one of the sponsors of the 2021 Psychedelic Investor Guide. KetaDASH is an Intravenous (IV) based, home delivery platform for patients who have been prescribed Ketamine. GlobeNewswire Inc

Oct 18, 2021

01:37PM EDT Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation Benzinga

Oct 13, 2021

04:25PM EDT There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are Benzinga

Oct 12, 2021

08:30AM EDT Ehave Hires Contract Research Organization To Conduct Ketamine GlobeNewswire Inc

Sep 30, 2021

08:30AM EDT Ehave, Inc. (OTC Pink: EHVVF) (the Company), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today the Psychedelic Stock Review has initiated coverage. GlobeNewswire Inc

Sep 27, 2021

08:30AM EDT Ehave, Inc., (OTC Pink: EHVVF) (the Company), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it has been included in the 2021 Psychedelic Investor Guide. GlobeNewswire Inc

Sep 25, 2021

09:15PM EDT Cannabis Movers & Shakers: Greenlight Distribution, Petalfast, Tinley Beverage, Shryne Group, Ehave, NY Cannabis Control Board Benzinga

Sep 21, 2021

08:30AM EDT Ehave Appoints Board-Certified Gastroenterologist And Licensed GlobeNewswire Inc

Sep 7, 2021

09:49AM EDT Ehave Announces Update On Ehave Medical App With The Launch Of GlobeNewswire Inc

Aug 25, 2021

09:43AM EDT Ehave Files 6-K Disclosing LOI Details For The Acquisition Of GlobeNewswire Inc

Aug 24, 2021

01:49PM EDT Ehave Accelerates Growth With LOI To Acquire India Based Moksha GlobeNewswire Inc

08:30AM EDT Ehave Files 6-K Disclosing Research Project Agreement GlobeNewswire Inc

Aug 11, 2021

08:30AM EDT Ehave acquires License covering G-20 Countries for all Psychedelic GlobeNewswire Inc

Aug 4, 2021

08:30AM EDT Ehave Partners with Globally Recognized University to Target GlobeNewswire Inc

Aug 2, 2021

01:26PM EDT FMW Medias New to The Street TV broadcasting its national syndicated show, TONIGHT, Monday, August 02, 2021 at 10:30 PM PT and Tuesday, Night, August 02, 2021 at 10:30PM PT on Fox Business Network. GlobeNewswire Inc

Jul 29, 2021

08:30AM EDT HPPD is a psychiatric disorder characterized by the persisting presence of sensory disturbances, most commonly visual, that resemble those produced by the use ofhallucinogenicsubstances. Ehave believes psychedelics are extremely safe, especially under medical supervision, but believes understanding HPPD will lead to a better understanding of these molecules as a whole GlobeNewswire Inc

Jul 27, 2021

02:45PM EDT FMW Medias New to The Street TV broadcasting its national syndicated show, TONIGHT, Tuesday, July 27, 2021 at 10:30 PM PT on Fox Business Network. GlobeNewswire Inc

Jul 23, 2021

10:32AM EDT FMW Medias New to The Street /Newsmax TV announces its TV airing of this weeks, Sunday, July 25, 2021, broadcasting line-up of its national syndicated 1- hour show, 10-11AM ET. GlobeNewswire Inc

Jul 9, 2021

09:31AM EDT Ehave Hires Institutional Review Board (IRB) As It Solidifies GlobeNewswire Inc

Jul 6, 2021

08:30AM EDT Former member of the National Advisory Council on Drug Abuse GlobeNewswire Inc

Jul 2, 2021

08:30AM EDT Ehave, Inc. To Be One Of Four Main Sponsors At The Third Annual GlobeNewswire Inc

Jul 1, 2021

08:30AM EDT Ehave, Inc. Adds Published Child, Adolescent And Adult GlobeNewswire Inc

Jun 29, 2021

08:30AM EDT Health Wizz Co-Founder, Dr. Nitin Desai, To Assist And Advise GlobeNewswire Inc

Jun 16, 2021

07:30AM EDT The Science Behind Using Psychedelics To Treat GlobeNewswire Inc

Jun 15, 2021

09:32AM EDT Dr. Jeffrey Kamlet Internationally Recognized Expert on Cardiac GlobeNewswire Inc

Jun 3, 2021

09:48AM EDT Ehave To Release Vaccine Passport As Part Of Its Medical Passport GlobeNewswire Inc

Jun 2, 2021

08:30AM EDT Ehave Expands Dashboard Capabilities to Include Decentralized GlobeNewswire Inc

May 20, 2021

06:30AM EDT Ehave KetaDASH Subsidiary Commences Data Collection for Potential GlobeNewswire Inc

Apr 22, 2021

12:33PM EDT Ehave, Inc. Announces Engagement of Legal Counsel to Advise on GlobeNewswire Inc

Apr 20, 2021

07:00AM EDT The Power of the Platform in Psychedelic Medicine GlobeNewswire Inc

Apr 16, 2021

07:30AM EDT Ehave Prepares to Launch Ketamine Clinical Trials Using Brain GlobeNewswire Inc

Apr 6, 2021

08:00AM EDT Life Clips, Inc. (OTC Pink: LCLP) (the Company), today announced that it has closed the acquisition of Cognitive Apps Software Solutions Inc. (Cognitive Apps), a developer of artificial intelligence (AI) applications for the healthcare industry and psychedelic research. GlobeNewswire Inc

Mar 23, 2021

07:00AM EDT Psilocybin Data Study Agreement Reached Between Ehave Inc. and GlobeNewswire Inc

Mar 22, 2021

07:00AM EDT Psychedelic Joint Venture Between Mycotopia Therapies and Natural GlobeNewswire Inc

Mar 12, 2021

12:01PM EST Ehave, Inc. (OTC Pink: EHVVF) (the Company), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today CEO and psychedelic thought leader, Benjamin Kaplan, will be featured on the Psychedelic Spotlight segment of New to the Street. The program will air on NewsMax on Sunday March 14th at 10:00 AM EST and Fox Business March 15th at 7:30 PM EST. GlobeNewswire Inc

Mar 3, 2021

08:30AM EST Ehave Inc. Files for KetaDash Trademark and to Uplist its Shares GlobeNewswire Inc

Feb 26, 2021

11:39AM EST Ehave Inc. Reaches Milestone; Ketamine IV Therapy Provider GlobeNewswire Inc

Feb 25, 2021

08:30AM EST Psychedelic Stocks Poised to Resume the Upward Trend GlobeNewswire Inc

Feb 17, 2021

08:30AM EST Ehave, Inc. to leverage data and AI to correlate biomarkers for the identification of psychedelic drug administration as a treatment for Chronic pain, Depression (major and persistent), PTSD, Bipolar disorder, General anxiety, ADHD and Schizophrenia GlobeNewswire Inc

Feb 11, 2021

08:30AM EST 264 Million Reasons Psychedelic Stocks Have More Room to Grow GlobeNewswire Inc

Feb 8, 2021

08:30AM EST Mycotopia Therapies (20/20 Global) to Launch PsyBioMed, a GlobeNewswire Inc

08:00AM EST 20/20 Global, Inc., (OTC Pink: TWGL) Mycotopia, a company focused on psychedelic therapies, announced today that it has applied to the Financial Industry Regulatory Authority ("FINRA") to change the name of the Company to Mycotopia Therapies Inc. The Company has also submitted an application to FINRA to change its stock symbol on OTC Market, requested symbol (MYCO). GlobeNewswire Inc

Feb 1, 2021

08:30AM EST Ehave Couples KetaDASH with Digital Therapeutics Expertise to GlobeNewswire Inc

Jan 27, 2021

08:30AM EST Ehave, Inc. (OTC Pink: EHVVF) (the Company), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it is exploring how palliative patients could benefit from its Ketamine home delivery platform, KetaDASH. GlobeNewswire Inc

Jan 26, 2021

08:30AM EST 20/20 Global, Inc. PsyTech the Worlds Most GlobeNewswire Inc

Jan 25, 2021

08:30AM EST Ehave, Inc. Utilizes Artificial Intelligence and Machine Learning GlobeNewswire Inc

08:30AM EST 4 Top Stocks for Huge Gains from the Psychedelic Renaissance GlobeNewswire Inc

Jan 22, 2021

08:30AM EST Ehave Closes Transaction to Acquire CureDash Assets, Adds KetaDASH GlobeNewswire Inc

Jan 21, 2021

08:52AM EST Medical records platform for psychedelic mental health to be available February 1 as a Plugin to the Ehave Dashboard. GlobeNewswire Inc

Jan 20, 2021

08:30AM EST Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now GlobeNewswire Inc

Jan 11, 2021

08:30AM EST Ehave Forms Partnership with Cognitive Apps to Introduce GlobeNewswire Inc

Jan 8, 2021

08:30AM EST Ehave, Inc. (OTC Pink: EHVVF) (the Company), a leader in digital therapeutics, announced today Patrick Gallagher has joined Ehave as Sales and Customer Acquisition Director. Mr. Gallagher will be responsible for building key customer relationships, sales channels for the Ehave Dashboard, and the suite of products offered through Ehave and its joint partnerships. GlobeNewswire Inc

Jan 7, 2021

08:30AM EST Ehave, Inc. Partners with Cognitive Apps to Add Artificial GlobeNewswire Inc

Jan 4, 2021

08:30AM EST Ehave, Inc. Files to List on the Canadian Stock Exchange and GlobeNewswire Inc

Dec 28, 2020

09:04AM EST 2020 Was The Year of Psychedelics Here's Why Benzinga

08:30AM EST Ehave, Inc. Announces Repositioning of Mycotopia Therapies to GlobeNewswire Inc

Dec 23, 2020

08:30AM EST Ketamine, originally approved by the FDA for anesthesia and pain relief, is now one of the psychedelics compounds being studied to treat mental health conditions like anxiety, addiction, and depression. GlobeNewswire Inc

Dec 21, 2020

08:00AM EST The Next Leg in the Bull Market for Psychedelic Stocks GlobeNewswire Inc

Dec 19, 2020

09:30AM EST Psyched: MDMA On Health Canada's Radar, MindMed Seeks FDA Support For LSD, Numinus Buys Mindspace Benzinga

Dec 17, 2020

08:30AM EST Ehave, Inc. (OTC Pink: EHVVF) (the Company), a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients, announces that Ben Kaplan, President, Chief Executive Officer and Chairman, has issued a letter to Ehave's stockholders. The full text is as follows: GlobeNewswire Inc

Dec 16, 2020

08:30AM EST Ehave, Inc. (OTC Pink: EHVVF) (the Company), a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients, today announced KetaDASH www.ketadash.com, an Intravenous (IV) based, home delivery platform for patients who have been prescribed Ketamine. GlobeNewswire Inc

Dec 8, 2020

07:30AM EST Big-Name Executives and Celebrities Open Up Opportunities for GlobeNewswire Inc

Dec 7, 2020

09:00AM EST Ehave, Inc. and Identity Key Announce Partnership for Blockchain GlobeNewswire Inc

Dec 4, 2020

09:00AM EST The Ehave Dashboard has the ability to segment data on-chain, which will allow developers, clinicians, researchers, doctors, hospitals, and universities to provide life-changing solutions to patients. GlobeNewswire Inc

Nov 9, 2020

09:15AM EST A recent report released by the Cybersecurity and Infrastructure Security Agency, part of the Department of Homeland Security, notes that the FBI and the Department of Health and Human Services have credible information of an increased and imminent cybercrime threat to US hospitals and healthcare providers. GlobeNewswire Inc

Oct 20, 2020

08:45AM EDT Ehave Expands Its Psychedelic Mental Health Platform with GlobeNewswire Inc

Oct 16, 2020

02:55AM EDT UPDATE - Trends in Psychedelic Drugs Research and Four Stocks You GlobeNewswire Inc

Sep 25, 2020

09:37AM EDT PsyTech Summit 2020 will be a one-day, international event bringing together decision makers, investors, clinicians, thought leaders, and advocates for the purpose of advancing psychedelics science, business, and reform. https://www.psytech.biz GlobeNewswire Inc

Sep 23, 2020

08:45AM EDT Ehave Recruiting Qualified Mental Health Professionals for Active GlobeNewswire Inc

Sep 22, 2020

08:45AM EDT Ehave, Inc. Launches Premier Psychedelic Retreat Centers GlobeNewswire Inc

Sep 8, 2020

08:45AM EDT The Licensing Agreement advances Ehaves mission to make medical records more portable. GlobeNewswire Inc

Sep 4, 2020

08:45AM EDT Ehave Signs Licensing Agreement to Enhance its Telemedicine Platform GlobeNewswire Inc

Sep 3, 2020

08:45AM EDT Psychedelic Capital produces a monthly virtual investor conference with the top performing companies in the psychedelic space. Investors can sign up at https://www.eventbrite.ca/e/psychedelic-capital-sept-the-gold-standard-for-psychedelic-investment-tickets-112539550826?discount=EHAVE GlobeNewswire Inc

Sep 2, 2020

08:45AM EDT Psychedelic medicine industry leaders share vision, answer questions live at https://www.psytech.biz/ethical-business-practice-registration/ GlobeNewswire Inc

Aug 26, 2020

09:00AM EDT Ehave to Release Doctors Dictation - An AI Powered Video and Voice GlobeNewswire Inc

Aug 24, 2020

08:45AM EDT Ehave Announces Plans to Accelerate the Monetization of its GlobeNewswire Inc

Aug 18, 2020

09:00AM EDT MDLink Announces Plans to Expand Into Central America GlobeNewswire Inc

Aug 12, 2020

08:45AM EDT MDLink to Launch IADB COVID-19 Screening Tool August 17 and Become GlobeNewswire Inc

Jul 24, 2020

09:00AM EDT Ehave, Inc. PsyTech The Worlds MOST RECOGNIZED GlobeNewswire Inc

Jul 22, 2020

07:00AM EDT U.S. Small Cap Stocks Could Outperform The Market During The GlobeNewswire Inc

Jul 21, 2020

10:53AM EDT MDLink Enters Technical Cooperation Agreement With The GlobeNewswire Inc

Share